Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AbbVie
Company Monitoring Page for AbbVie
latest headlines for company on cafepharma
Could This FDA Approval Boost AbbVie's Stock?
Motley Fool
Wed, 01/18/23 - 09:49 am
Tags:
AbbVie
,
Vraylar
,
major depressive disorcer
Biopharma's stock market winners of 2022 revealed
EP Vantage
Wed, 01/18/23 - 09:46 am
Tags:
pharma stocks
,
Merck
,
Eli Lilly
,
AbbVie
,
Daiichi Sankyo
,
Vertex Pharmaceuticals
,
Takeda
,
Sarepta Therapeutics
,
Halozyme
,
Horizon Therapeutics
AbbVie and Lilly have sent a warning signal to the UK government by leaving the voluntary medicines pricing agreement in protest over increasingly punitive revenue clawbacks
ABPI
Tue, 01/17/23 - 10:38 am
Tags:
AbbVie
,
Eli Lilly
,
UK
,
NHS
,
drug pricing
Looking past Humira, AbbVie boosts sales forecasts for successor drugs
BioPharma Dive
Wed, 01/11/23 - 12:22 pm
Tags:
JPMHC 2023
,
AbbVie
,
Richard Gonzalez
,
Pharma CEOs
,
Humira
,
Skyrizi
,
Rinvoq
AbbVie, following in footsteps of Lilly and Takeda, pays Anima $42M to go after undruggable targets
Fierce Biotech
Tue, 01/10/23 - 11:05 am
Tags:
AbbVie
,
Anima Biotech
,
MRNA
,
small molecule drugs
,
oncology
,
immunology
,
undruggable targets
AbbVie inks Immunome solid tumor deal that could top $2.8B in biobucks
Fierce Biotech
Sun, 01/8/23 - 10:07 pm
Tags:
AbbVie
,
Immunome
,
biobucks
,
solid tumors
The biggest-selling pharma companies of 2023
EP Vantage
Wed, 01/4/23 - 05:20 pm
Tags:
Pfizer
,
Merck
,
JNJ
,
Novartis
,
AbbVie
,
Roche
AbbVie's Vraylar, carrying $4B sales target, wins FDA label expansion in depression
Fierce Pharma
Mon, 12/19/22 - 10:05 pm
Tags:
AbbVie
,
Vraylar
,
depression
,
FDA
AbbVie leaves PhRMA, BIO: reports
Medical Marketing and Media
Thu, 12/15/22 - 11:20 pm
Tags:
AbbVie
,
BIO
,
PhRMA
,
lobbying
AbbVie, Ipsen exit R&D deals to cap off lousy year for Exicure
Fierce Biotech
Wed, 12/14/22 - 10:44 am
Tags:
Exicure
,
AbbVie
,
Ipsen
,
R&D
AbbVie slapped with age discrimination lawsuit, following other pharmas
Endpoints
Mon, 12/12/22 - 10:31 am
Tags:
AbbVie
,
age discrimination
,
legal
ASH: Roche touts Lunsumio's durable efficacy as AbbVie, Regeneron plot lymphoma bispecific battle
Fierce Pharma
Mon, 12/12/22 - 10:21 am
Tags:
Roche
,
ASH 2022
,
AbbVie
,
Regeneron
,
lymphoma
,
Lunsumio
,
glofitamab
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline
BioSpace
Tue, 12/6/22 - 10:42 am
Tags:
AbbVie
,
HotSpot Therapeutics
,
drug discovery
,
drug development
,
autoimmune disease
BMS' Zeposia and AbbVie's Skyrizi Shake Up First-Line Prescribing Patterns in the US Ulcerative Colitis and Crohn's Disease Markets, Spherix Reports
PR Newswire
Sun, 12/4/22 - 01:24 pm
Tags:
Bristol Myers Squibb
,
AbbVie
,
Zeposia
,
Skyrizi
,
ulcerative colitis
,
Crohn's Disease
,
gastroentrologists
10 Massachusetts Biopharma Companies Hiring Now
BioSpace
Fri, 12/2/22 - 11:18 am
Tags:
Massachusetts
,
hirings
,
AbbVie
,
Moderna Therapeutics
,
CSL
,
Intellia Therapeutics
,
Schrödinger
,
Visterra
,
Alloy Therapeutics
,
Werewolf Therapeutics
,
Sherlock Biosciences
AbbVie links up with London VC firm to map out new anti-inflammatory companies
Fierce Biotech
Tue, 11/29/22 - 10:42 am
Tags:
AbbVie
,
venture capital
,
London
,
Deep Science Ventures
,
inflammatory diseases
Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits
Fierce Pharma
Sat, 11/26/22 - 07:11 pm
Tags:
Teva Pharmaceutical
,
AbbVie
,
Allergan
,
opioids
,
legal
,
opioid crisis
AbbVie's Roche-rivaling blood cancer bispecific gets FDA priority review, triggering Genmab payday
Fierce Biotech
Mon, 11/21/22 - 10:12 am
Tags:
AbbVie
,
Genmab
,
FDA
,
Roche
,
epcoritamab
,
bispecific antibodies
,
relapsed or refractory large B-cell lymphoma
Optum to add biosimilars to formulary to tackle the massive cost of Humira
Fierce Healthcare
Wed, 11/16/22 - 11:16 pm
Tags:
OptumRx
,
AbbVie
,
Humira
,
biosimilars
AbbVie inks $54M settlement to resolve Namenda 'pay-for-delay' lawsuit
Fierce Pharma
Tue, 11/15/22 - 06:37 pm
Tags:
legal
,
AbbVie
,
Namenda
,
Alzheimer's disease
,
pay-for-delay
,
Allergan
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.